Home
Conditions
Hematologic Diseases

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,344 public trials 2,835 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, Not Recruiting

Telementoring Intervention (ECHO) for the Transformation of Professional Engagement, Practice Efficiency, and Community Building Through Team Meetings in Diagnostic Imaging Clinicians

NCT04196972

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hematopoietic and Lymphoid Cell Neoplasm, +4 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Peritransplant Ruxolitinib for Patients With Primary and Secondary Myelofibrosis

NCT04384692

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Active, Not Recruiting

A Phase II Study Using Ibrutinib and Short-Course Fludarabine in Treatment-Naive CLL

NCT02514083

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Active, Not Recruiting

Study Investigating Patient-Reported Outcomes in Lower-risk MDS Patients

NCT05582902

Conditions: Anemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations: Universitätsklinik Innsbruck Innsbruck, Austria

Charité Universitätsmedizin Berlin Berlin, Germany

Klinikum Chemnitz gGmbH Chemnitz, Germany

Gemeinschaftspraxis Hämatologie-Onkologie Dresden, Germany

View Trial Details

Active, Not Recruiting

Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant

NCT03192397

Conditions: Acute Myeloid Leukemia in Remission, Adult Acute Lymphoblastic Leukemia in Complete Remission, Anemia, +45 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Active, Not Recruiting

CPX-351 (Vyxeos™) for Transplant Eligible, Higher Risk Patients With Myelodysplastic Syndrome

NCT03572764

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

Washington University School of Medicine St Louis, Missouri, United States

Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Active, Not Recruiting

A Clinical Trial of Four Medicines (Elranatamab Plus Carfilzomib and Dexamethasone or Maplirpacept) in People With Relapsed Refractory Multiple Myeloma

NCT05675449

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations: University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

Beverly Hills Cancer Center Beverly Hills, California, United States

Clinical Research Advisors (Encino Satellite Location) Encino, California, United States

Clinical Research Advisors (Korea Town Satellite Location) Los Angeles, California, United States

View all 36 locations

View Trial Details

Active, Not Recruiting

Analysis of Effectiveness and Safety of Teclistamab in Relapsed and Refractory Multiple Myeloma Patients

NCT06062537

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: CHU Amiens Picardie Amiens, France

CH d'ANNECY Annecy, France

Centre hospitalier d'Argenteuil Argenteuil, France

Hopital de la cote Basque Bayonne, France

View all 31 locations

View Trial Details

Active, Not Recruiting

PCI-32765 (Ibrutinib) in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-cell Prolymphocytic Leukemia

NCT01589302

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +17 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Active, Not Recruiting

A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma

NCT05572515

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations: Alaska Oncology and Hematology LLC Anchorage, Alaska, United States

Banner MD Anderson Cancer Center Gilbert, Arizona, United States

Alta Bates Comprehensive Cancer Center Berkeley, California, United States

MemorialCare Long Beach Medical Center Long Beach, California, United States

View all 211 locations

View Trial Details

Hematologic Diseases

Hematologic Diseases trial results

Related conditions